<code id='2A28CE3E2A'></code><style id='2A28CE3E2A'></style>
    • <acronym id='2A28CE3E2A'></acronym>
      <center id='2A28CE3E2A'><center id='2A28CE3E2A'><tfoot id='2A28CE3E2A'></tfoot></center><abbr id='2A28CE3E2A'><dir id='2A28CE3E2A'><tfoot id='2A28CE3E2A'></tfoot><noframes id='2A28CE3E2A'>

    • <optgroup id='2A28CE3E2A'><strike id='2A28CE3E2A'><sup id='2A28CE3E2A'></sup></strike><code id='2A28CE3E2A'></code></optgroup>
        1. <b id='2A28CE3E2A'><label id='2A28CE3E2A'><select id='2A28CE3E2A'><dt id='2A28CE3E2A'><span id='2A28CE3E2A'></span></dt></select></label></b><u id='2A28CE3E2A'></u>
          <i id='2A28CE3E2A'><strike id='2A28CE3E2A'><tt id='2A28CE3E2A'><pre id='2A28CE3E2A'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:969
          Senator Ron Wyden (D-OR) speaks with reporters in the Senate subway at the U.S. Capitol
          Sen. Ron Wyden (D-Ore.) Drew Angerer/Getty Images

          Senate Finance Committee members from both parties took aim Wednesday at insurance brokers that sell plans for large Medicare Advantage insurers.

          Older adults at times have more than 100 plan options, and brokers help them choose the right one. But brokers can be incentivized by large insurance companies to aggressively sell plans that are a poor fit for the Medicare beneficiaries they’re supposed to help. Brokers also sometimes collect private information that they sell to multiple insurance companies. Those brokers tend to have a national scope, just like the large insurers they represent, compared to the independent, local brokers.

          advertisement

          “They are big private marketing companies in the middle between seniors and their coverage,” Chairman Ron Wyden (D-Ore.) said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Amylyx's ALS drug launch starts strong. It could be trouble for FDA
          Amylyx's ALS drug launch starts strong. It could be trouble for FDA

          MollyFerguson/STATBehindthestellarcommerciallaunchofAmylyxPharmaceuticals’treatmentforALSliesanuncom

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          Quicker fix for pulse oximeters urged during FDA public meeting

          AdobeTheFoodandDrugAdministrationshouldmovemorequicklytoensurepulseoximeters—theubiquitousdevicesuse